InnovAge Holding Corp. Net Income (Loss) Attributable to Noncontrolling Interest
InnovAge Holding Corp. (INNV) reported Net Income (Loss) Attributable to Noncontrolling Interest of $1.85 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-09-09
- InnovAge Holding Corp. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $1.50M.
- InnovAge Holding Corp. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$479.00K, a 295.51% decline year-over-year.
- InnovAge Holding Corp. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $1.19M.
- InnovAge Holding Corp. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$350.00K.
- InnovAge Holding Corp. net income (loss) attributable to noncontrolling interest for fiscal 2026 was $1.85M.
- InnovAge Holding Corp. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$5.03M.
- InnovAge Holding Corp. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$1.88M.
- InnovAge Holding Corp. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$2.88M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $1.02M derived: sum of 2 quarters · filed 2026-09-09 | $2.20M derived: sum of 3 quarters · filed 2026-09-09 | $1.85M 10-K · filed 2026-09-09 |
| 2026-03-31 | -$479.00K 10-Q · filed 2026-05-08 | $708.00K derived: sum of 2 quarters · filed 2026-05-08 | $358.00K 10-Q · filed 2026-05-08 | -$3.87M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $1.19M 10-Q · filed 2026-02-03 | $837.00K 10-Q · filed 2026-02-03 | -$3.39M derived: sum of 3 quarters · filed 2026-09-09 | -$3.14M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | -$350.00K 10-Q · filed 2025-11-04 | -$4.57M derived: sum of 2 quarters · filed 2026-09-09 | -$4.33M derived: sum of 3 quarters · filed 2026-09-09 | -$4.60M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | -$4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$3.98M derived: sum of 2 quarters · filed 2026-09-09 | -$4.25M derived: sum of 3 quarters · filed 2026-09-09 | -$5.03M 10-K · filed 2026-09-09 |
| 2025-03-31 | $245.00K 10-Q · filed 2026-05-08 | -$25.00K derived: sum of 2 quarters · filed 2026-05-08 | -$806.00K 10-Q · filed 2026-05-08 | -$1.36M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$270.00K 10-Q · filed 2026-02-03 | -$1.05M 10-Q · filed 2026-02-03 | -$1.60M derived: sum of 3 quarters · filed 2026-02-03 | -$1.90M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$781.00K 10-Q · filed 2025-11-04 | -$1.33M derived: sum of 2 quarters · filed 2025-11-04 | -$1.63M derived: sum of 3 quarters · filed 2025-11-04 | -$2.01M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$554.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | -$851.00K derived: sum of 2 quarters · filed 2025-09-09 | -$1.23M derived: sum of 3 quarters · filed 2025-09-09 | -$1.88M 10-K · filed 2025-09-09 |
| 2024-03-31 | -$297.00K 10-Q · filed 2025-05-06 | -$671.00K derived: sum of 2 quarters · filed 2025-05-06 | -$1.33M 10-Q · filed 2025-05-06 | -$2.15M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$374.00K 10-Q · filed 2025-02-04 | -$1.03M 10-Q · filed 2025-02-04 | -$1.85M derived: sum of 3 quarters · filed 2025-02-04 | -$2.53M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | -$658.00K 10-Q · filed 2024-11-05 | -$1.48M derived: sum of 2 quarters · filed 2024-11-05 | -$2.16M derived: sum of 3 quarters · filed 2024-11-05 | -$2.91M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$818.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | -$1.50M derived: sum of 2 quarters · filed 2024-09-10 | -$2.25M derived: sum of 3 quarters · filed 2024-09-10 | -$2.88M 10-K · filed 2024-09-10 |
| 2023-03-31 | -$680.00K 10-Q · filed 2024-05-07 | -$1.43M derived: sum of 2 quarters · filed 2024-05-07 | -$2.06M 10-Q · filed 2024-05-07 | -$2.88M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$754.00K 10-Q · filed 2024-02-06 | -$1.38M 10-Q · filed 2024-02-06 | -$2.20M derived: sum of 3 quarters · filed 2024-02-06 | -$2.54M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | -$626.00K 10-Q · filed 2023-11-07 | -$1.45M derived: sum of 2 quarters · filed 2023-11-07 | -$1.79M derived: sum of 3 quarters · filed 2023-11-07 | -$2.00M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$823.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | -$1.16M derived: sum of 2 quarters · filed 2023-09-12 | -$1.38M derived: sum of 3 quarters · filed 2023-09-12 | -$1.44M 10-K · filed 2023-09-12 |
| 2022-03-31 | -$337.00K 10-Q · filed 2023-05-09 | -$554.00K derived: sum of 2 quarters · filed 2023-05-09 | -$616.00K 10-Q · filed 2023-05-09 | -$775.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$217.00K 10-Q · filed 2023-02-07 | -$279.00K 10-Q · filed 2023-02-07 | -$438.00K derived: sum of 3 quarters · filed 2023-02-07 | -$790.00K derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | -$62.00K 10-Q · filed 2022-11-08 | -$221.00K derived: sum of 2 quarters · filed 2022-11-08 | -$573.00K derived: sum of 3 quarters · filed 2022-11-08 | -$671.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | -$511.00K derived: sum of 2 quarters · filed 2022-09-13 | -$609.00K derived: sum of 3 quarters · filed 2022-09-13 | -$754.00K 10-K · filed 2022-09-13 |
| 2021-03-31 | -$352.00K 10-Q · filed 2022-05-10 | -$450.00K derived: sum of 2 quarters · filed 2022-05-10 | -$595.00K 10-Q · filed 2022-05-10 | -$715.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$98.00K 10-Q · filed 2022-02-09 | -$243.00K 10-Q · filed 2022-02-09 | -$363.00K derived: sum of 3 quarters · filed 2022-02-09 | -$511.00K derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | -$146.00K 10-Q · filed 2021-11-09 | -$265.00K derived: sum of 2 quarters · filed 2021-11-09 | -$413.00K derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | -$119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | -$267.00K derived: sum of 2 quarters · filed 2021-09-23 | -$513.00K 10-K · filed 2021-09-23 | |
| 2020-03-31 | -$148.00K 10-Q · filed 2021-05-11 | -$394.00K 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |